Dyne Therapeutics, Inc. DYN
16.69 USD -0.35 -2.05%
At close
16.98 +0.29 +1.74%
Pre-market · Nov 2, 5:21 AM ET
14.00 52-week range 27.31
- YTD
- -14.67%
- 1 year
- -29.13%
- Open
- 17.04
- Prev close
- 17.04
- Mkt cap
- 3.12B
- Vol
- 1.45M
- Avg vol
- 2.77M
- EPS
- -3.30
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.34
- High
- 17.19
- Forward P/E
- -5.04
- Beta
- 1.12
- Short ratio
- 7.94
- Inst. own
- 103.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 18.72
- 200-d avg
- 19.31
- 1y target
- 34.33
5D chart
Chart tools
Chart is warming up
The five-day price history for DYN has not been loaded yet. Try again in a moment.
Altman Z-Score
3.41 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
P/E -5.6×
P/S 0.0×
P/B 2.6×
P/FCF -6.2×
EV/EBITDA -3.7×
EV/Sales 0.0×
FCF Yield -16.1%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -45.9%
ROIC -41.0%
ROA -37.6%
Revenue 0.0%
Operating Income -36.1%
EPS (diluted) -3.0%
Free Cash Flow -37.4%
Current Ratio 22.3×
Quick Ratio 22.3×
Debt / Equity 0.0×
Net Debt / EBITDA 2.0×
Interest Coverage -75.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31